BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 4, 2007
View Archived Issues
BioGeneriX and Neose extend GlycoPEG-GCSF collaboration
Read More
NovaDel raises funds to advance oral spray drug candidates
Read More
Thalidomide to be evaluated for the treatment of MIA syndrome in dialysis patients / News in Context
Read More
Grazax launched in U.K., Denmark and Norway
Read More
FDA approval for generic Atenolol Tablets
Read More
Shandong Luye acquires cancer drug CMNa
Read More
Exelixis and Genentech sign agreement for MEK inhibitor XL-518
Read More
4SC and XL TechGroup form new company to develop biofilm inhibitors
Read More
Grifols receives FDA approval for new generation of IVIG
Read More
Zydus launches Simvastatin Tablets
Read More
Perrigo receives FDA approval for Ciclopirox Topical Suspension
Read More
REG1 anticoagulant system safe in humans
Read More
VGX-1027 active against diabetes in preclinical models
Read More
PRO-132365 investigated in breast cancer trial
Read More
E75 vaccine safe and active in high-risk breast cancer
Read More
Novel monoamine reuptake inhibitors emerge from NeuroSearch R&D
Read More
Novel antibacterial agents patented
Read More
New CCR-5 receptor modulators prepared and tested at Kemia
Read More
Higher recovery rate after stroke for DP-b99-treated patients
Read More
Transdur-Bupivacaine begins phase II for postherpetic neuralgia
Read More
Phase II program under way for TD-1792 in Gram-positive cSSSI
Read More
SPA agreement for pivotal phase III study of picoplatin in SCLC
Read More
U.K. clearance for clinical study of Reolysin with docetaxel in advanced cancers
Read More